Written by: Saket 2/23/2010 11:29 AM
The FDA report said that if every diabetic taking rosiglitazone had been prescribed a similar drug called Pioglitazone,500 heart attacks and 300 cases of heart failure would have been averted in the US every month ,NEW YORK TIMES reported on Sunday,quoting the confidential FDA report.While GSK holds the patent for rosiglitazone in the US(brand name Avandia),the drug is prescribed and sold under 10 different brand names to 8 million people in India,where it was launched in 2001.Rosiglitazone was once one of the largest selling drugs in the world,before a 2007 study published in The New England Journal of Medicine found it harmed the heart and prompted the FDA to issue a warning.POPULAR BRANDS IN INDIA ARE as Winindia(GSK),Rosicon(Glenmark),Rezult(Sun Pharma), Senzia(Cipla),Enselin(Torrent),Reglit(Dr Reddy's),Roglin(Aristo),Rosinorm(Micro),Rosizon(Emcure),Rozon(Wallace).
0 comments so far...